Recursion Pharmaceuticals （纳斯达克股票代码：RXRX）首席执行官Christopher Gibson于2025年10月23日以5.70美元的价格出售了10万股A类普通股，总计57万美元。此次出售发生时，该公司股票交易价格为6.03美元，公司当前市值为26亿美元。根据 InvestingPro ...

These are direct-prediction models trained from scratch on small, heavily augmented datasets—not few-shot prompting. ARC remains the canonical target; broader leaderboard context and rules (e.g., ...

The MLB postseason is underway, some exciting baseball has already been played and some more is around the corner for the next month or so. In order to properly enjoy this postseason, there are a few ...

There was an error while loading. Please reload this page. A modular identity framework for Large Language Models, derived from recursive-tone experiments with ...

This week, I had to make one of the most difficult decisions of my career: saying goodbye to 20% of the team at Recursion. The process was extraordinarily painful, and the costs were heartbreakingly ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

Altitude Labs, a biotechnology accelerator backed by Recursion Pharmaceuticals, on Wednesday said it is launching a new fund to give pre-seed grants to life sciences researchers and startups disrupted ...